GABAPENTIN

Product NDC
81279-126
11-digit product format
812790126
Labeler code
81279
Product ID
81279-126_526cf9ed-8502-fed9-e063-6394a90adf42
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
GABAPENTIN
Dosage form
CAPSULE
Route
ORAL
Labeler
Pangea Pharmaceuticals, LLC
Application
ANDA219319
Marketing category
ANDA
Marketing start
2026-05-22
Substance
GABAPENTIN
Active strength
200 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219319-001GABAPENTINGABAPENTIN100MGCAPSULE / ORALAB2025-08-07
A219319-002GABAPENTINGABAPENTIN300MGCAPSULE / ORALAB2025-08-07
A219319-003GABAPENTINGABAPENTIN400MGCAPSULE / ORALAB2025-08-07
A219319-004GABAPENTINGABAPENTIN200MGCAPSULE / ORALAB2026-05-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A219319-001AB
A219319-002AB
A219319-003AB
A219319-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A219319-001GABAPENTIN100MGCAPSULE / ORALAB2025-08-07011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219319-002GABAPENTIN300MGCAPSULE / ORALAB2025-08-07011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219319-003GABAPENTIN400MGCAPSULE / ORALAB2025-08-07011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219319-001GABAPENTIN100MGCAPSULE / ORALAB2025-08-0731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219319-002GABAPENTIN300MGCAPSULE / ORALAB2025-08-0731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219319-003GABAPENTIN400MGCAPSULE / ORALAB2025-08-0731067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219319-001GABAPENTIN100MGCAPSULE / ORALAB2025-08-07a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219319-002GABAPENTIN300MGCAPSULE / ORALAB2025-08-07a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219319-003GABAPENTIN400MGCAPSULE / ORALAB2025-08-07a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219319-004GABAPENTIN200MGCAPSULE / ORALAB2026-05-14a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A219319-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219319-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219319-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219319-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219319-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219319-003AB131067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219319-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219319-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219319-003AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219319-004AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
GABAPENTIN
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GABAPENTIN200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
6CW7F3G59XInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2739001Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5eff7ad8-0d31-4372-82a2-ac9f549d8796Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cdc2ae60-922e-452d-a42f-787fe4e2ed06Product name120250123
7059096a-4b9f-36c2-db50-bb5c723e6e9eProduct name220250114
fa3f0129-3502-889f-f424-3a37727959e7Product name920181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81279-126-60GABAPENTIN60 in 1 BOTTLECAPSULE601

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GABAPENTINGABAPENTINPangea Pharmaceuticals, LLC5eff7ad8-0d31-4372-82a2-ac9f549d87962026-05-22Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219319
application number: ANDA219319
ndc (product): 81279-126
GabapentinGABAPENTINAmici Pharma, Inc.1ea83c18-7107-41f4-8305-62725c1c45c82026-05-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219319
application number: ANDA219319
GABAPENTINGABAPENTINSTALLION LABORATORIES PRIVATE LIMITEDb26fd0c6-6aab-4957-8a32-cc7adb9b5fc92025-10-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219319
application number: ANDA219319

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2739001gabapentin 200 MG Oral CapsulePSN5eff7ad8-0d31-4372-82a2-ac9f549d87961
2739001gabapentin 200 MG Oral CapsuleSCD5eff7ad8-0d31-4372-82a2-ac9f549d87961
2739001gabapentin 200 MG Oral CapsuleSY5eff7ad8-0d31-4372-82a2-ac9f549d87961

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
81279-126-608127901266060 CAPSULE in 1 BOTTLE (81279-126-60) 60 capsule2026-05-22NoNoCurrent